Pharma Payment Guides
Educational resources to help you understand pharmaceutical industry payments, federal disclosure requirements, and how to use Open Payments data in your healthcare decisions.
All guides reference CMS Open Payments PY2024 data covering 6,000+ companies and $13.3 billion in reported payments across 51 states.
Understanding the Open Payments Program
What the Sunshine Act requires, how CMS collects payment data, and what types of transfers must be reported by pharma and device companies.
Pharma Payment Types Explained
The difference between research payments, consulting fees, speaking fees, and food and beverage payments — and what each category reveals about the physician-industry relationship.
Why Pharma Payment Transparency Matters
How payment data helps patients make informed decisions, what research shows about payments and prescribing patterns, and how to use PlainPharmaWatch effectively.
How Much Do Pharma Companies Spend on Doctors?
A data-driven analysis of the $13.3B in PY2024 payments — total spending by category, year-over-year trends, geographic distribution, and which companies spend the most.
Drug Company Marketing Practices
How pharmaceutical companies use speaker bureaus, consulting fees, advisory boards, and research funding to shape physician prescribing — and what Open Payments data reveals.
Important Note
These guides are for informational purposes only. Payment data does not imply wrongdoing. Many industry-physician relationships are legitimate and beneficial. Always consult your own healthcare provider for medical decisions.
Methodology
Our guides are based on publicly available data from authoritative government sources. All statistics, ratings, and figures cited in these guides are drawn directly from official datasets and publications, with sources clearly referenced throughout.
We aim to present complex government data in plain language that is accessible to general audiences. When methodologies differ between data sources or change over time, we note these variations inline. Our editorial process includes regular reviews to ensure accuracy and timeliness of the information presented.